623 related articles for article (PubMed ID: 18626268)
1. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
2. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
[TBL] [Abstract][Full Text] [Related]
3. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective serotonin reuptake inhibitors on the risk of fracture.
Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D;
Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321
[TBL] [Abstract][Full Text] [Related]
5. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
6. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
Ginzburg R; Rosero E
Ann Pharmacother; 2009 Jan; 43(1):98-103. PubMed ID: 19116378
[TBL] [Abstract][Full Text] [Related]
7. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
[TBL] [Abstract][Full Text] [Related]
8. Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort.
Carrière I; Farré A; Norton J; Wyart M; Tzourio C; Noize P; Pérès K; Fourrier-Réglat A; Ancelin ML
Osteoporos Int; 2016 Nov; 27(11):3187-3195. PubMed ID: 27311722
[TBL] [Abstract][Full Text] [Related]
9. Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Tamblyn R; Bates DW; Buckeridge DL; Dixon WG; Girard N; Haas JS; Habib B; Iqbal U; Li J; Sheppard T
J Am Geriatr Soc; 2020 Jul; 68(7):1494-1503. PubMed ID: 32181493
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
11. Rates of bone loss among women initiating antidepressant medication use in midlife.
Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
[TBL] [Abstract][Full Text] [Related]
12. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
13. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
Renoux C; Vahey S; Dell'Aniello S; Boivin JF
JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
[TBL] [Abstract][Full Text] [Related]
14. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures.
Verdel BM; Souverein PC; Egberts TC; van Staa TP; Leufkens HG; de Vries F
Bone; 2010 Sep; 47(3):604-9. PubMed ID: 20601295
[TBL] [Abstract][Full Text] [Related]
15. Weight outcomes among antidepressant users in nursing facilities.
Rigler SK; Webb MJ; Redford L; Brown EF; Zhou J; Wallace D
J Am Geriatr Soc; 2001 Jan; 49(1):49-55. PubMed ID: 11207842
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
[TBL] [Abstract][Full Text] [Related]
19. Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?
Warden SJ; Fuchs RK
Curr Osteoporos Rep; 2016 Oct; 14(5):211-8. PubMed ID: 27495351
[TBL] [Abstract][Full Text] [Related]
20. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
